LAS VEGAS, Oct. 19, 2026 (GLOBE NEWSWIRE) — GBank Financial Holdings Inc. (the “Company”) (Nasdaq: GBFH), the parent company for GBank (the “Bank”), today announced it plans to release its third quarter 2026 financial results on Wednesday, October 28, 2026 at approximately 1:05 p.m. PST, and will host its quarterly earnings call on Wednesday, October 28, 2026, at 2:00 p.m. PST. Interested parties can participate remotely via Internet connectivity. There will be no physical location for attendance.

Interested parties may register for the event using this link:

https://gbank-financial-earnings-q326.open-exchange.net/

About GBank Financial Holdings Inc.

GBank Financial Holdings Inc. is a bank holding company headquartered in Las Vegas, Nevada and is listed on the Nasdaq Capital Market under the symbol “GBFH.” Our national payment and Gaming FinTech business lines serve gaming clients across the U.S. and feature the GBank Visa Signature® Card—a tailored product for the gaming and sports entertainment markets. The Bank is also a top national SBA lender, now operating across 40 states. Through our wholly owned bank subsidiary, GBank, we operate two full-service commercial branches in Las Vegas, Nevada to provide a broad range of business, commercial and retail banking products and services to small businesses, middle-market enterprises, public entities and affluent individuals in Nevada, California, Utah, and Arizona. Please visit www.gbankfinancialholdings.com for more information.

Available Information

The Company routinely posts important information for investors on its web site (under www.gbankfinancialholdings.com and, more specifically, under the News & Media tab at www.gbankfinancialholdings.com/press-releases). The Company intends to use its web site as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD (Fair Disclosure) promulgated by the U.S. Securities and Exchange Commission (the “SEC”). Accordingly, investors should monitor the Company’s web site, in addition to following the Company’s press releases, SEC filings, public conference calls, presentations and webcasts.

The information contained on, or that may be accessed through, the Company’s web site is not incorporated by reference into, and is not a part of, this document.

For Further Information, Contact:

GBank Financial Holdings Inc.
Edward M. Nigro
Chairman and CEO
702-851-4200
enigro@g.bank

Source: GBank Financial Holdings Inc.

CHIHUAHUA, Mexico, Oct. 19, 2026 (GLOBE NEWSWIRE) — GCC, S.A.B. de C.V. (BMV: GCC*; the “Company”), a leading producer of cement and concrete in the United States and Mexico, announced today that, following the favorable arbitral award obtained on November 5, 2025, the Company entered into a settlement agreement and received a gross payment of US$71.5 million. The arbitration proceeding arose in connection with GCC’s sale, in 2011, of its equity interest in SOBOCE, S.A. to Consorcio Cementero del Sur, S.A.

As a result of the execution of the settlement agreement and receipt of the payment, the dispute has been fully and finally resolved, with no further liability for GCC in connection therewith.

This material event is disclosed in accordance with Article 50 of the Circular Única de Emisoras.

About GCC

GCC is a leading supplier and producer of cement, concrete, aggregates, and construction‐related services in the United States, Mexico and Canada, with an annual cement production capacity of 6 million metric tons. Founded in 1941, the Company’s shares are listed on the Mexican Stock Exchange under the ticker symbol GCC*.

Forward-Looking Statements

This press release may contain forward-looking statements. All statements that are not clearly historical in nature are forward-looking, and the words “anticipate,” “believe,” “expect,” “estimate,” “intend,” “project” and similar expressions are generally intended to identify forward-looking statements. These statements are subject to risks and uncertainties including, among others, changes in macroeconomic, political, legal, public health crises, governmental or business conditions in the markets where GCC operates; changes in interest rates, inflation rates and currency exchange rates; performance of the construction industry; and pricing, business strategy and other factors. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may differ materially from the beliefs, projections, and estimates described herein. GCC assumes no obligation to update the information contained in this press release.

For further information, contact:

GCC Investor Relations

Sahory Ogushi

+52 (614) 442 3176

+ 1 (303) 739 5943

soguship@gcc.com

CHIHUAHUA, Mexico, Oct. 19, 2026 (GLOBE NEWSWIRE) — GCC, S.A.B. de C.V. (BMV: GCC*; the “Company”), a leading producer of cement and concrete in the United States and Mexico, announced today that, following the favorable arbitral award obtained on November 5, 2025, the Company entered into a settlement agreement and received a gross payment of US$71.5 million. The arbitration proceeding arose in connection with GCC’s sale, in 2011, of its equity interest in SOBOCE, S.A. to Consorcio Cementero del Sur, S.A.

As a result of the execution of the settlement agreement and receipt of the payment, the dispute has been fully and finally resolved, with no further liability for GCC in connection therewith.

This material event is disclosed in accordance with Article 50 of the Circular Única de Emisoras.

About GCC

GCC is a leading supplier and producer of cement, concrete, aggregates, and construction‐related services in the United States, Mexico and Canada, with an annual cement production capacity of 6 million metric tons. Founded in 1941, the Company’s shares are listed on the Mexican Stock Exchange under the ticker symbol GCC*.

Forward-Looking Statements

This press release may contain forward-looking statements. All statements that are not clearly historical in nature are forward-looking, and the words “anticipate,” “believe,” “expect,” “estimate,” “intend,” “project” and similar expressions are generally intended to identify forward-looking statements. These statements are subject to risks and uncertainties including, among others, changes in macroeconomic, political, legal, public health crises, governmental or business conditions in the markets where GCC operates; changes in interest rates, inflation rates and currency exchange rates; performance of the construction industry; and pricing, business strategy and other factors. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may differ materially from the beliefs, projections, and estimates described herein. GCC assumes no obligation to update the information contained in this press release.

For further information, contact:

GCC Investor Relations

Sahory Ogushi

+52 (614) 442 3176

+ 1 (303) 739 5943

soguship@gcc.com

VANCOUVER, British Columbia, Oct. 19, 2026 (GLOBE NEWSWIRE) — Patagonia Gold Corp. (“Patagonia” or the “Company”) (TSXV: PGDC) announces that it has filed an independent technical report entitled “Calcatreu Project, Rio Negro Province, Argentina, Preliminary Economic Assessment, NI 43-101 Technical Report”, dated October 2, 2026, and having an effective date of January 14, 2026 (the “Technical Report”) for its flagship Calcatreu Gold-Silver Project (“Calcatreu”), located in Río Negro Province, Argentina.

The Technical Report was prepared in accordance with National Instrument 43-101 – Standards of Disclosure for Mineral Projects by NCL Ingeniería y Construcción SpA and supports the preliminary economic assessment and updated mineral resource estimate for Calcatreu that were disclosed in the Company’s news release dated September 28, 2026, as corrected by the Company’s news release dated October 6, 2026. The Technical Report is available under the Company’s profile on SEDAR+ (at www.sedarplus.ca).

About Patagonia Gold

Patagonia Gold Corp. is a South America focused, publicly traded, mining company listed on the TSX Venture Exchange. The Company seeks to grow shareholder value through exploration and development of gold and silver projects in the Patagonia region of Argentina. The Company is primarily focused on the Calcatreu project in Rio Negro and the development of the Cap-Oeste underground project. Patagonia, indirectly through its subsidiaries or under option agreements, has mineral rights to over 375 properties in several provinces of Argentina and is one of the largest landholders in the province of Santa Cruz, Argentina.

For more information, please contact:

Christopher van Tienhoven, Chief Executive Officer
Patagonia Gold Corp.
T: +54 11 5278 6950
E: cvantienhoven@patagoniagold.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

VANCOUVER, British Columbia, Oct. 19, 2026 (GLOBE NEWSWIRE) — Patagonia Gold Corp. (“Patagonia” or the “Company”) (TSXV: PGDC) announces that it has filed an independent technical report entitled “Calcatreu Project, Rio Negro Province, Argentina, Preliminary Economic Assessment, NI 43-101 Technical Report”, dated October 2, 2026, and having an effective date of January 14, 2026 (the “Technical Report”) for its flagship Calcatreu Gold-Silver Project (“Calcatreu”), located in Río Negro Province, Argentina.

The Technical Report was prepared in accordance with National Instrument 43-101 – Standards of Disclosure for Mineral Projects by NCL Ingeniería y Construcción SpA and supports the preliminary economic assessment and updated mineral resource estimate for Calcatreu that were disclosed in the Company’s news release dated September 28, 2026, as corrected by the Company’s news release dated October 6, 2026. The Technical Report is available under the Company’s profile on SEDAR+ (at www.sedarplus.ca).

About Patagonia Gold

Patagonia Gold Corp. is a South America focused, publicly traded, mining company listed on the TSX Venture Exchange. The Company seeks to grow shareholder value through exploration and development of gold and silver projects in the Patagonia region of Argentina. The Company is primarily focused on the Calcatreu project in Rio Negro and the development of the Cap-Oeste underground project. Patagonia, indirectly through its subsidiaries or under option agreements, has mineral rights to over 375 properties in several provinces of Argentina and is one of the largest landholders in the province of Santa Cruz, Argentina.

For more information, please contact:

Christopher van Tienhoven, Chief Executive Officer
Patagonia Gold Corp.
T: +54 11 5278 6950
E: cvantienhoven@patagoniagold.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

DALLAS, Oct. 19, 2026 (GLOBE NEWSWIRE) — Dorchester Minerals, L.P. (the “Partnership”) announces today that it has entered into an agreement to acquire mineral and royalty interests.

On October 16, 2026, the Partnership entered into a non-taxable contribution and exchange agreement with an unrelated third party to acquire mineral and royalty interests totaling approximately 4,300 net royalty acres located in three counties across the Williston Basin in North Dakota. Cash received by the contributing entity attributed to the acquired interests on or after July 1, 2026, will be contributed to the Partnership at closing. The contributing entity will convey its interests to the Partnership in exchange for 1,250,000 common units representing limited partnership interests in Dorchester Minerals, L.P. The acquisition is expected to close on October 30, 2026, subject to customary closing conditions.

Dorchester Minerals, L.P. is a Dallas-based owner of oil and natural gas mineral, royalty, overriding royalty, net profits, and leasehold interests located in 28 states. Its common units trade on the NASDAQ Global Select Market under the symbol DMLP.

FORWARD-LOOKING STATEMENTS

Portions of this document may constitute “forward-looking statements” as defined by federal law. Such statements are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected. Examples of such uncertainties and risk factors include, but are not limited to, changes in the price or demand for oil and natural gas, changes in the operations on or development of the Partnership’s properties, changes in economic and industry conditions and changes in regulatory requirements (including changes in environmental requirements) and the Partnership’s financial position, business strategy and other plans and objectives for future operations. These and other factors are set forth in the Partnership’s filings with the Securities and Exchange Commission.

Contact:
Martye Miller
3838 Oak Lawn Ave., Suite 300
Dallas, Texas 75219-4541
(214) 559-0300

DALLAS, Oct. 19, 2026 (GLOBE NEWSWIRE) — Dorchester Minerals, L.P. (the “Partnership”) announces today that it has entered into an agreement to acquire mineral and royalty interests.

On October 16, 2026, the Partnership entered into a non-taxable contribution and exchange agreement with an unrelated third party to acquire mineral and royalty interests totaling approximately 4,300 net royalty acres located in three counties across the Williston Basin in North Dakota. Cash received by the contributing entity attributed to the acquired interests on or after July 1, 2026, will be contributed to the Partnership at closing. The contributing entity will convey its interests to the Partnership in exchange for 1,250,000 common units representing limited partnership interests in Dorchester Minerals, L.P. The acquisition is expected to close on October 30, 2026, subject to customary closing conditions.

Dorchester Minerals, L.P. is a Dallas-based owner of oil and natural gas mineral, royalty, overriding royalty, net profits, and leasehold interests located in 28 states. Its common units trade on the NASDAQ Global Select Market under the symbol DMLP.

FORWARD-LOOKING STATEMENTS

Portions of this document may constitute “forward-looking statements” as defined by federal law. Such statements are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected. Examples of such uncertainties and risk factors include, but are not limited to, changes in the price or demand for oil and natural gas, changes in the operations on or development of the Partnership’s properties, changes in economic and industry conditions and changes in regulatory requirements (including changes in environmental requirements) and the Partnership’s financial position, business strategy and other plans and objectives for future operations. These and other factors are set forth in the Partnership’s filings with the Securities and Exchange Commission.

Contact:
Martye Miller
3838 Oak Lawn Ave., Suite 300
Dallas, Texas 75219-4541
(214) 559-0300

Leo International Precision Health AG: Mr Leo Wang, Disposal

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them,
19. Oct 2026 / 23:55 CET/CEST, transmitted by GlobeNewswire.

The issuer is solely responsible for the content of this announcement.


1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Title Mr
First name Leo
Last name Wang

2. Reason for the notification

a) Position / status

Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Leo International Precision Health AG

b) LEI

529900R5095181VD8H48

4. Details of the transaction(s)

a) Description of the financial instrument

Type Share
ISIN DE0005490601

b) Nature of the transaction

Disposal

c) Price(s) and volume(s)

Price(s) Volume(s)
0.0054 EUR 22,882.00 EUR

d) Aggregated information

Price Aggregated volume
0.0054 EUR 22,882.00 EUR

e) Date of the transaction (CET/CEST)

14.10.2026

f) Place of the transaction

Outside a trading venue

End of message


GlobeNewsWire Distribution Services include regulatory announcements, financial/corporate news and press releases.

Archive at www.globenewswire.com


Language English
Company Leo International Precision Health AG
Am Klopferspitz 19
82152 Planegg / Martinsried
Germany
Internet https://www.liphag.com

Leo International Precision Health AG: Mr Leo Wang, Disposal

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them,
19. Oct 2026 / 23:55 CET/CEST, transmitted by GlobeNewswire.

The issuer is solely responsible for the content of this announcement.


1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Title Mr
First name Leo
Last name Wang

2. Reason for the notification

a) Position / status

Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Leo International Precision Health AG

b) LEI

529900R5095181VD8H48

4. Details of the transaction(s)

a) Description of the financial instrument

Type Share
ISIN DE0005490601

b) Nature of the transaction

Disposal

c) Price(s) and volume(s)

Price(s) Volume(s)
0.0054 EUR 22,882.00 EUR

d) Aggregated information

Price Aggregated volume
0.0054 EUR 22,882.00 EUR

e) Date of the transaction (CET/CEST)

14.10.2026

f) Place of the transaction

Outside a trading venue

End of message


GlobeNewsWire Distribution Services include regulatory announcements, financial/corporate news and press releases.

Archive at www.globenewswire.com


Language English
Company Leo International Precision Health AG
Am Klopferspitz 19
82152 Planegg / Martinsried
Germany
Internet https://www.liphag.com

TORONTO, Oct. 19, 2026 (GLOBE NEWSWIRE) — Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced that it has granted an aggregate of 1,600,000 stock options to purchase common shares of the Company to officers of the Company pursuant to the Company’s Omnibus Equity Incentive Plan (the “Plan”).

The stock options are exercisable at a price of C$0.20 per common share and have a term of ten years from the date of grant. The options vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining 75% vesting in equal monthly instalments over the subsequent 36 months, subject to the terms of the Plan.

The grant of these stock options remains subject to the approval of the TSX Venture Exchange.

About Conavi Medical

Conavi Medical is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. Its patented hybrid imaging system is the first system to co-register and co-align intravascular ultrasound (IVUS) and optical coherence tomography (OCT) imaging beams to enable simultaneous hybrid imaging of coronary arteries. The hybrid imaging system has 510(k) clearance from the U.S. Food and Drug Administration. For more information, visit http://www.conavi.com/.

Forward looking information

This press release includes forward-looking information or forward-looking statements within the meaning of applicable securities laws regarding the Company and its business, which may include, but are not limited to, statements with respect to the commercialization and commercial launch of Conavi’s hybrid imaging system and the timing thereof, the sufficiency of Conavi’s resources to achieve such commercial launch, the global market opportunity for coronary intravascular imaging (including for IVUS and OCT), the continued growth in adoption of and in the clinical validation and guideline support for intravascular imaging and the ability of Conavi’s hybrid imaging system to meet market needs. All statements that are, or information which is, not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking information or statements”. Often but not always, forward-looking information or statements can be identified by the use of words such as “shall”, “intends”, “anticipate”, “believe”, “plan”, “expect”, “intend”, “estimate” or any variations (including negative variations) of such words and phrases, or state that certain actions, events or results “may”, “might”, “can”, “could”, “would” or “will” be taken, occur, lead to, result in, or, be achieved. Such statements are based on the current expectations and views of future events of the management of the Company. They are based on assumptions and subject to risks and uncertainties. Although management believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this release, may not occur and could differ materially as a result of known and unknown risk factors and uncertainties affecting the Company, including, without limitation, those listed in the “Risk Factors” section of the annual information form of the Company dated February 26, 2026 (available on the Company’s profile at www.sedarplus.ca). Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Accordingly, readers should not place undue reliance on any forward-looking statements or information. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Company does not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.

No regulatory authority has approved or disapproved the content of this press release. Neither the TSX Venture Exchange nor its Regulatory Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

Contact

Mark Quick, Chief Financial Officer | 416-483-0100
Christina Cameron, Investor Relations | 416-483-0100 ext. 121 | IR@conavi.com

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.